Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 91-100 of 224

Page
per page
  1. LY2784544
    A4147 LY2784544
    Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3K
    Summary: JAK2 inhibitor,highly potent and selective
      ≥23.5 mg/mL
  2. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL
  3. GSK2879552
    B5879 GSK2879552
     1 Citation
    Target: LSD
    Summary: Novel and irreversible LSD1 inhibitor
      insoluble in EtOH; ≥10.14 mg/mL
  4. XL019
    A3937 XL019
    Target: JAK
    Summary: JAK2 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥11.125 mg/mL
  5. Nanaomycin A
    A8191 Nanaomycin A
     2 Citation
    Summary: DNMT3B inhibitor
      insoluble in H2O; ≥15.1 mg/mL
  6. NVP-BSK805
    A3675 NVP-BSK805
    Summary: ATP-competitive JAK2 inhibitor
      ≥20.95 mg/mL
  7. Nexturastat A
    B3704 Nexturastat A
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,highly potent and selective
      insoluble in H2O; ≥16.3 mg/mL
  8. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL
  9. MCB-613
    A8712 MCB-613
    Target: Src
    Summary: stimulator of steroid receptor coactivator (SRC)
      insoluble in H2O; ≥13.2 mg/mL
  10. MK-4827
    A3617 MK-4827
    Target: PARP
    Summary: PARP-1/-2 inhibitor,potent and selective
      ≥32 mg/mL

Items 91-100 of 224

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 23item
  2. Aurora Kinase 24item
  3. DNA Methyltransferase 2item
  4. HDAC 34item
  5. Histone Acetyltransferases 10item
  6. Histone Demethylases 15item
  7. Histone Methyltransferase 32item
  8. HIF 4item
  9. JAK 29item
  10. MBT Domains 1 item
  11. PARP 18item
  12. Pim 4item
  13. Protein Ser/Thr Phosphatases 11item
  14. RNA Polymerase 2item
  15. Sirtuin 10item
  16. Sphingosine Kinase-2 1 item
  17. Polycomb repressive complex 2item
  18. SUMOylation 2item
  19. PAD 1 item
Specificity
  1. Selective 67item
Reversibility
  1. Reversible 6item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 19item
  3. PI3K 1 item
  4. Aurora Kinases 16item
  5. EZH2 3item
  6. Bromodomains 7item
  7. FLT3 4item
  8. PLK 1 item
  9. VEGFR 1 item
  10. RET 1 item
  11. Hydrolase 1 item
  12. MEK 1 item
  13. DOT1L 2item
  14. FGFR 2item
  15. Pim 1 item
  16. Sir2-like Family Deacetylases (Sirtuins) 3item
  17. Src 4item
  18. Trk Receptors 1 item
  19. STAT 1 item
  20. Hypoxia Inducible Factors (HIFs) 1 item
  21. Tankyrases 1 item
  22. JAK 13item
  23. EZH1 1 item
  24. TNKS 1 item
  25. SMYD2 1 item
  26. CREBBP 1 item
  27. EP300 1 item
  28. LRRK2 1 item
  29. PARP 6item
  30. ALK 1 item
  31. Bromodomain and Extra-Terminal motif (BET) 1 item
  32. NAT10 1 item
  33. G9a 1 item
  34. Hck 1 item
  35. SETD7 1 item
  36. Histone Demethylases 1 item
  37. Protein Arginine Methyltransferases 1 item
  38. c-RET 1 item
  39. VEGFR3/FLT4 1 item
  40. NTRK1/TRKA 1 item
  41. CSF-1R/c-Fms 1 item
  42. HDAC 2item
  43. KDM 1 item
  44. HIF-PH 1 item
  45. L3MBTL 1 item
  46. TYK2 1 item
  47. MUSK 1 item
  48. MAP3K 1 item
  49. Lck 1 item
  50. FGR 1 item
  51. YES 1 item
  52. Fyn 1 item
  53. ARG 1 item
  54. LSD 1 item
  55. PRMT 1 item
  56. SK 1 item
Reported Experiments
  1. Animal Experiments 74item
  2. Cell Experiments 58item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 8item
  3. Bladder Cancer 1 item
  4. Breast Cancer 15item
  5. Cancer 56item
  6. Castration-resistant Prostate Cancer 1 item
  7. Cervical Cancer 2item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 8item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 1 item
  12. Diabetes 1 item
  13. Diffuse Large B-cell Lymphoma 1 item
  14. Dyskinesia 1 item
  15. Friedreich's Ataxia 1 item
  16. Glioblastoma 1 item
  17. Hepatic Cancer 1 item
  18. HIV 2item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 3item
  21. Leukemia 3item
  22. Lung Cancer 4item
  23. Lymphoma 4item
  24. Melanoma 2item
  25. Mixed Lineage Leukemia 2item
  26. Multiple Myeloma 3item
  27. Myelofibrosis 1 item
  28. Neuroblastoma 2item
  29. Non-small Cell Lung Cancer 2item
  30. Ovarian Cancer 3item
  31. Pancreatic Cancer 3item
  32. Prostate Cancer 7item
  33. Psoriasis 1 item
  34. Renal Cancer 1 item
  35. Rheumatoid Arthritis 1 item
  36. Type 2 Diabetes 2item